Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000950170-24-127129
Filing Date
2024-11-14
Accepted
2024-11-14 16:36:32
Documents
102
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A atai-20240930.htm   iXBRL 10-Q/A 3849481
2 EX-31.1 atai-ex31_1.htm EX-31.1 14937
3 EX-31.2 atai-ex31_2.htm EX-31.2 16265
4 EX-31.3 atai-ex31_3.htm EX-31.3 17115
5 EX-32.1 atai-ex32_1.htm EX-32.1 18958
6 GRAPHIC img106867992_0.jpg GRAPHIC 84765
  Complete submission text file 0000950170-24-127129.txt   19030701

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT atai-20240930.xsd EX-101.SCH 3184158
104 EXTRACTED XBRL INSTANCE DOCUMENT atai-20240930_htm.xml XML 3702660
Mailing Address WALLSTRASSE 16 BERLIN 2M 10179
Business Address WALLSTRASSE 16 BERLIN 2M 10179 49 89 2153 9035
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-40493 | Film No.: 241463442
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)